Andersen and Dopharma join forces in Spain!
Andersen and Dopharma are announcing the signing of an agreement for the marketing of their veterinary pharmaceutical products in Spain through a new Joint Venture named Dopharma Iberia.
Andersen, a company dedicated to the sale of veterinary pharmaceutical products, medicated premixes, pharmacological specialties and ingredients and additives for animal nutrition with 45 years of experience since the beginning of its operations in Spain and export markets, also has a strong focus on excellence and specialization in nutritional products.
Dopharma, a Dutch veterinary pharmaceutical company with a focus on livestock, has been active for 50 years in the market and is currently selling its products in more than 50 countries around the world with approximately 40 distribution partners.
The combination of both portfolio’s, skills and expertise is joined now in Dopharma Iberia and will enforce their presence in the Spanish market.
The portfolio of Dopharma Iberia will consist of products for livestock animals including poultry, bovine, equine and swine, both oral and injectable formulations.
Dopharma Iberia will start with their commercial operations in September 2019.
The detail of our products in this link: https://www.dopharma-iberia.com/producto-categoria/productos/